Taylor Leavitt is a Partner at Leavitt Partners and heads the company’s Equity Practice, directing investment decisions that align with the partnership’s core beliefs about the future of health care.

Prior to joining Leavitt Partners, Mr. Leavitt worked for ZARS Pharma, a venture capital funded pharmaceutical company, engaged in corporate licensing and business development operations. While at ZARS, Mr. Leavitt identified, negotiated and executed strategic corporate transactions on a global basis, including merger and acquisitions, national and international product licenses, IP and technology licenses and R&D alliances. During this time at ZARS Pharma, Mr. Leavitt managed the commercial launch of ZARS’ first FDA approved product, which achieved steady growth with a lean, efficient infrastructure. Mr. Leavitt was also responsible for the ZARS Pharma New Products Committee, which recommends new and licensed products to the executive board.

Prior to ZARS Pharma, Mr. Leavitt was a founding employee for the Park City Center for Public Policy. In other capacities, Mr. Leavitt has worked with Epic Venture Capital, SAIC, and Keystone Global Investment LLC.
Mr. Leavitt received a master’s degree in business administration from the UCLA Anderson School of Business with an emphasis in private equity and entrepreneurship. He graduated magna cum laude with his bachelor’s degrees in finance, economics and international business from Utah State University.